References
- Anonīms (2008). Sociālā sistēma un veselības aprūpe Rīgā 2007. gadā: Rīgas Domes Labklājības departamenta gadagrāmata [Social system and health care in Rīga in 2007]. Rīga, 7. lpp.
- Anonymous (1999a). Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE Study Group. Diabetologia, 42, 647-654.
- Anonymous (1999b). WHO Consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus.
- http://whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf
- Anonymous (2000). World Health Organization Report No. 99.2. Report of WHO Consultation: Obesity: Preventing and managing the global epidemic. Geneva, WHO Technical Report Series, 894.
- Anonymous (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Diabetes Prevention Program Research Group. New Engl. J. Med., 346, 393-403.
- Anonymous (2003). Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. The DECODE Study Group. Diabetes Care, 26, 61-69.
- Anonymous (2005). IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation.
- http://www.idf.org/webdata/docs/MetSyndrome_FINAL.pdf
- Baan, C.A., Ruige, J.B. & Stolk, R.P. (1999). Performance of a predictive model to identify undiagnosed diabetes in a health care setting. Diabetes Care, 22, 213-19.
- Colditz, G.A., Willett, W.C., Rotnitzky, A., Manson J.E. (1995). Weight gain as a risk factor for clinical diabetes mellitus in women. Ann. Intern. Med., 122, 481-486.
- Glumer, C., Carstensen, B., Sandbaek, A., Lauritzen, T., Jorgensen, T., Borch-Johnsen, K.A. (2004). Danish diabetes risk score for targeted screening: The Inter99 study. Diabetes Care, 27, 727-733.
- Griffin, S.J., Little, P.S., Hales, C.N., Kinmonth, A.L., Wareham, N.J. (2000). Diabetes risk score: Towards earlier detection of type 2 diabetes in general practice. Diabetes Metab. Res. Rev., 16, 164-171.
- Harris, M.I. (1996). Impaired glucose tolerance: Prevalence and conversion to NIDDM. Diabet Med., 13(Suppl), 9-11.
- Hunt, K., Williams, K., Haffner, S., Stern, M. (2002). Predicting impaired glucose tolerance among individuals with non-diabetic fasting glucose value: The San Antonio Heart Study. Diabetes, 2, SA229.
- Hu, F.B., Manson, J.E., Stampfer, M.J., Colditz, G., Liu, S., Solomon, C.G., Willet W.C. (2001). Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. New Engl. J. Med., 345, 790-797.
- King, H., Aubert, R.E., Herman W.H. (1998). Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care, 21, 1414-1431.
- Knowler, W.C., Barrett-Connor, E., Fowler, S.E. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl. J. Med., 346, 393-403.
- Kosaka, K., Noda, M., Kuzuya, T. (2005). Prevention of type 2 diabetes by lifestyle intervention: A Japanese trial in IGT males. Diabetes Res. Clin. Pract., 67, 152-162.
- Lindström,. J., Tuomilehto, J. (2003). The diabetes risk score: A practical tool to predict type 2 diabetes risk. Diabetes Care, 26, 725-731.
- Lindstrom, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J.G., Hemiö, K., Hämäläinen, Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Mannelin, M., Paturi, M., Sundvall, J., Valle, TT., Uusitupa, M., Tuomilehto, J. (2006). Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: Follow-up of the Finnish Diabetes Prevention Study. Lancet, 368, 1673-1679.
- Lorenzo, C., Okoloise, M., Williams, K., Stern, M.P., Haffner, S.M. (2003). The metabolic syndrome as predictor of type 2 diabetes: The San Antonio heart study. Diabetes Care, 26, 3153-3159.
- Kumanyika, S., Jeffery R.W., Morabia, A., Ritenbaugh C., Antipatis V.J. (2002). Obesity prevention: The case for action. Public Health Approaches to the Prevention of Obesity (PHAPO) Working Group of the International Obesity Task Force (IOTF). Int. J. Obes. Relat. Metab. Disord., 26, 425-436.
- Must, A., Spadano, J., Coakley, E.H., Field, A.E., Colditz, G., Dietz, W.H. (2007). The disease burden associated with overweight and obesity. JAMA, 282, 1523-1529.
- Nathan, D.M., Davidson, M.B., DeFronzo, R.A., Heine, R.J., Henry, R.R., Pratley, R., Zinman, B. (2007). ADA Consensus Statement. Impaired fasting glucose and impaired glucose tolerance: Implications for care. Diabetes Care, 30, 753-759.
- Pan, X.R., Li, G.W., Hu, Y.H. (1997). Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care, 20, 537-544.
- Park, P.J., Griffin, S.J., Sargeant, L., Wareham, N.J. (2002). The performance of a risk score in predicting undiagnosed hyperglycemia. Diabetes Care, 25, 984-988.
- Pīrāgs, V., Bricina, N., Dzērve, V. & Eisaka, I. (2005). Pirmās nacionālās cukura diabēta skrīninga programmas DIA-screen rezultāti [The results of the first diabetes screening programme DIA-screen]. In: Latvijas Universitātes Raksti, Vol. 694, Medicīna, IV, 85.-91. lpp.
- Pudule, I. (2007). Latvijas iedzīvotāju veselību ietekmējošo paradumu pētījums, 2006. [Health Behaviour among Latvian Adult Population, 2006]. Rīga: V/a Sabiedrības veselības agentūra. 165 lpp.
- Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A.D., Vijay, V. Indian Diabetes Prevention Programme (IDPP). (2006). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia, 49, 289-297.
- Rathmann, W., Haastert, B., Icks, A., Löwel, H., Meisinger, C., Holle, R., Giani, G. (2000). High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000. Diabetologia, 46, 182-189.
- Saaristo, T., Peltonen, M., Linström, J., Saarikoski, L., Sundvall, J., Eriksson, J. G., Tuomilehto, J. (2005). Cross-sectional evaluation of the Finnish Diabetes Risk Score: A tool to identify undetected type diabetes, abnormal glucose tolerance and metabolic syndrome. Diabetes Vasc. Dis. Res., 2, 67-72.
- Saaristo, T., Barengo, N. C., Korpi-Hyövälti, E., Oksa, H., Puolijoki, H., Saltevo, J. T., Vanhala, M., Sundvall, J., Saarikoski, L., Peltonen, M., Tuomilehto, J. (2008). High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population. BMC Public Health, 8, 423-431.
- Schmidt, M.I., Duncan, B.B., Vigo, A., Pankow, J., Ballantyne, C.M., Couper, D., Brancati, F., Folsom, A.R. for the ARIC investigators (2003). Detection of undiagnosed diabetes and other hyperglycemia states: The Atherosclerosis Risk in Communities Study. Diabetes Care, 26, 1338-1343.
- Swinburn, B.A., Metcalf, P.A., Ley, S.J. (2001). Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care, 24, 619-624.
- Tuomilehto, J., Lindström, J., Eriksson, J.G. (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New Engl. J. Med., 344, 1343-1350.
- Wild, S.G., Roglic, A., Green, R., Sicree, H., King, F. (2004). Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 27, 1047-1053.
- Zargar, A.H., Khan, A.K., Masoodi, S.R., Laway, B.A., Wani, A.I., Bashir, M.I., Dar, F.A. (2000). Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in the Kashmir Valley of the Indian subcontinent. Diabetes Res. Clin. Pract., 47, 135-146.